Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells
- 31 July 2004
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 112 (1) , 54-65
- https://doi.org/10.1016/j.clim.2004.03.011
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Enhancing antimelanoma immune responses through apoptosisCancer Gene Therapy, 2003
- The Fas Signaling Pathway: More Than a ParadigmScience, 2002
- 15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in ratsJournal of Clinical Investigation, 2000
- Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cellsCell Death & Differentiation, 1999
- Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.Journal of Clinical Investigation, 1997
- Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.The Journal of Experimental Medicine, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Type II Collagen Autoimmunity in Animals and Provocations Leading to ArthritisImmunological Reviews, 1990
- Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell cultureCancer Letters, 1980